LOW vs ZVRA · P/E 18, rev $49.03B vs P/E 6.3, rev $75.9M
Lowe's Companies Inc (LOW) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE. It is led by Marvin R. Ellison.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported LOW revenue for 2026-07-31 was $49.03B. Net income was $4.03B. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the LOW and ZVRA stock pages for the full models.
Not investment advice.